KR101042042B1 - 변형된 락톤 고리를 갖는 캄토테신 - Google Patents

변형된 락톤 고리를 갖는 캄토테신 Download PDF

Info

Publication number
KR101042042B1
KR101042042B1 KR1020047016880A KR20047016880A KR101042042B1 KR 101042042 B1 KR101042042 B1 KR 101042042B1 KR 1020047016880 A KR1020047016880 A KR 1020047016880A KR 20047016880 A KR20047016880 A KR 20047016880A KR 101042042 B1 KR101042042 B1 KR 101042042B1
Authority
KR
South Korea
Prior art keywords
homocamptothecin
compounds
mmol
formula
delete delete
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020047016880A
Other languages
English (en)
Korean (ko)
Other versions
KR20050036909A (ko
Inventor
마지마우로
마라스토니엘레나
펜코세르지오
피사노클라우디오
틴티마리아오르넬라
베시로레다나
주니노프란코
베르가니도메니코
카브리왈터
알페기아니마르코
파트리시오마틴고메즈
다넬리타마라
Original Assignee
이스티튜토나치오날레페르로스튜디오에라쿠라데이투모리
시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 이스티튜토나치오날레페르로스튜디오에라쿠라데이투모리, 시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이. filed Critical 이스티튜토나치오날레페르로스튜디오에라쿠라데이투모리
Publication of KR20050036909A publication Critical patent/KR20050036909A/ko
Application granted granted Critical
Publication of KR101042042B1 publication Critical patent/KR101042042B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Epoxy Compounds (AREA)
KR1020047016880A 2002-05-31 2003-05-28 변형된 락톤 고리를 갖는 캄토테신 Expired - Fee Related KR101042042B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM2002A000305 2002-05-31
IT2002RM000305A ITRM20020305A1 (it) 2002-05-31 2002-05-31 Camptotecine con anello lattonico modificato.

Publications (2)

Publication Number Publication Date
KR20050036909A KR20050036909A (ko) 2005-04-20
KR101042042B1 true KR101042042B1 (ko) 2011-06-16

Family

ID=11456338

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020047016880A Expired - Fee Related KR101042042B1 (ko) 2002-05-31 2003-05-28 변형된 락톤 고리를 갖는 캄토테신

Country Status (22)

Country Link
US (1) US7273873B2 (https=)
EP (2) EP1719775B1 (https=)
JP (1) JP4693410B2 (https=)
KR (1) KR101042042B1 (https=)
CN (1) CN1656100A (https=)
AR (1) AR040139A1 (https=)
AT (2) ATE403659T1 (https=)
AU (2) AU2003241160B2 (https=)
BR (2) BR0311333A (https=)
CA (2) CA2485201C (https=)
CY (2) CY1107311T1 (https=)
DE (2) DE60322754D1 (https=)
DK (2) DK1719775T3 (https=)
ES (2) ES2273002T7 (https=)
IT (1) ITRM20020305A1 (https=)
MX (1) MXPA04011682A (https=)
PE (1) PE20050120A1 (https=)
PL (1) PL374346A1 (https=)
PT (2) PT1719775E (https=)
SI (2) SI1511752T1 (https=)
TW (1) TWI325866B (https=)
WO (1) WO2003101995A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2852606A1 (fr) * 2003-03-18 2004-09-24 Inst Nat Sante Rech Med Moyens pour inhiber simultanement l'expression de plusieurs genes impliques dans une pathologie
ITRM20030344A1 (it) * 2003-07-14 2005-01-15 Ist Naz Stud Cura Dei Tumori 7-n-poliamminoalchil(ossi)imminometilcamptotecine recanti gruppi protettivi.
PT2170900E (pt) 2007-08-01 2013-01-24 Sigma Tau Ind Farmaceuti Forma cristalina ii de 7-(dimetoximetil)-camptotecina, sua utilização como intermediário e produtos obtidos a partir dela
CN102746314B (zh) * 2011-04-18 2016-07-06 华东师范大学 含有稳定7元内酯环的喜树碱类化合物、制备方法和用途
CN104530066A (zh) * 2015-01-06 2015-04-22 华东师范大学 一类新型高喜树碱衍生物、制备方法和用途
CA3099155A1 (en) 2018-05-14 2019-11-21 Nuvation Bio Inc. Anti-cancer nuclear hormone receptor-targeting compounds
CA3138197A1 (en) 2019-05-14 2020-11-19 Nuvation Bio Inc. Anti-cancer nuclear hormone receptor-targeting compounds
EP4058464A1 (en) 2019-11-13 2022-09-21 Nuvation Bio Inc. Anti-cancer nuclear hormone receptor-targeting compounds
MX2023011241A (es) 2021-03-23 2023-10-03 Nuvation Bio Inc Compuestos dirigidos a receptores de hormonas nucleares contra el cancer.
JP2024516024A (ja) 2021-05-03 2024-04-11 ニューベイション・バイオ・インコーポレイテッド 抗がん核内ホルモン受容体標的化化合物
WO2024073626A2 (en) * 2022-09-28 2024-04-04 Nuvation Bio Inc. Anti-cancer nuclear hormone receptor-targeting compounds

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990028263A (ko) * 1995-06-21 1999-04-15 제라르드 보푸르 캄프토테신의 신규 동족체, 그의 제조 방법, 그의 의학 용도 및그를 포함하는 제약 조성물
WO2000053607A1 (en) * 1999-03-09 2000-09-14 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Camptothecin derivatives having antitumor activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57116076A (en) * 1981-01-09 1982-07-19 Yakult Honsha Co Ltd Novel camptothecin derivative and its preparation
US4399276A (en) * 1981-01-09 1983-08-16 Kabushiki Kaisha Yakult Honsha 7-Substituted camptothecin derivatives
FR2532591A1 (fr) 1982-09-02 1984-03-09 Hutchinson Nouveau dispositif de securite pour pneumatiques de vehicules ou autres engins

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990028263A (ko) * 1995-06-21 1999-04-15 제라르드 보푸르 캄프토테신의 신규 동족체, 그의 제조 방법, 그의 의학 용도 및그를 포함하는 제약 조성물
WO2000053607A1 (en) * 1999-03-09 2000-09-14 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Camptothecin derivatives having antitumor activity

Also Published As

Publication number Publication date
ES2312090T3 (es) 2009-02-16
WO2003101995A3 (en) 2004-02-19
EP1719775A1 (en) 2006-11-08
KR20050036909A (ko) 2005-04-20
PL374346A1 (en) 2005-10-17
WO2003101995A8 (en) 2004-12-23
DE60322754D1 (de) 2008-09-18
DE60308368T3 (de) 2010-09-16
EP1511752B1 (en) 2006-09-13
EP1511752B3 (en) 2010-03-10
CN1656100A (zh) 2005-08-17
DE60308368D1 (de) 2006-10-26
BR0311329A (pt) 2005-02-22
CY1108793T1 (el) 2014-04-09
DK1511752T5 (da) 2010-06-14
AU2003241160A1 (en) 2003-12-19
JP4693410B2 (ja) 2011-06-01
AU2009236044A1 (en) 2009-12-03
EP1511752A2 (en) 2005-03-09
AU2009236044A8 (en) 2011-07-21
EP1511752B8 (en) 2007-04-18
US20050154003A1 (en) 2005-07-14
AU2003241160B2 (en) 2009-08-20
EP1719775B1 (en) 2008-08-06
AU2009236044B8 (en) 2011-07-21
CA2485201A1 (en) 2003-12-11
WO2003101995A2 (en) 2003-12-11
JP2005531602A (ja) 2005-10-20
BR0311333A (pt) 2005-03-15
AU2009236044B2 (en) 2011-03-24
TWI325866B (en) 2010-06-11
US7273873B2 (en) 2007-09-25
ITRM20020305A1 (it) 2003-12-01
PE20050120A1 (es) 2005-03-04
AR040139A1 (es) 2005-03-16
CY1107311T1 (el) 2012-11-21
ES2273002T3 (es) 2007-05-01
MXPA04011682A (es) 2005-03-31
ES2273002T7 (es) 2011-08-01
ITRM20020305A0 (it) 2002-05-31
TW200404806A (en) 2004-04-01
ATE339422T1 (de) 2006-10-15
ATE403659T1 (de) 2008-08-15
PT1719775E (pt) 2008-09-30
DK1511752T3 (da) 2007-01-29
PT1511752E (pt) 2007-01-31
CA2706635A1 (en) 2003-12-11
DE60308368T2 (de) 2007-09-06
DK1719775T3 (da) 2008-11-17
CA2485201C (en) 2010-11-02
SI1719775T1 (sl) 2009-04-30
SI1511752T1 (sl) 2007-02-28

Similar Documents

Publication Publication Date Title
AU2009236044B8 (en) Camptothecins with a modified lactone ring
EP1044977B1 (en) Camptothecin derivatives having antitumor activity
KR100191193B1 (ko) 6환 화합물
US4981968A (en) Synthesis of camptothecin and analogs thereof
CA3200649A1 (en) Novel camptothecin derivative, composition containing same, and use thereof
KR101000963B1 (ko) 캄토테신의 20 번 위치의 에스테르
AU7182500A (en) New dihydrofuro (3,4-b) quinolin-1-one compounds, a process for their preparation and pharmaceutical compositions containing them
JP7822664B2 (ja) Ｐｔｐｎ２阻害剤
AU760863B2 (en) Optically pure camptothecin analogues, optically pure synthesis intermediate and method for preparing same
NO342506B1 (no) Camptotecinderivater med antitumoraktivitet
JP2025507758A (ja) Ｍａｌｔ１のｐｒｏｔａｃｓ
JPH01131161A (ja) Ｎ−〔置換アルキリデン〕融合−ビシクロアルキリデン及びヘテロアルキリデンキノリンアミン
HK1031222B (en) Camptothecin derivatives having antitumor activity
HK1135693B (en) Camptothecin derivatives with antitumor activity
HK1135693A1 (en) Camptothecin derivatives with antitumor activity

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

J201 Request for trial against refusal decision
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PJ0201 Trial against decision of rejection

St.27 status event code: A-3-3-V10-V11-apl-PJ0201

PB0901 Examination by re-examination before a trial

St.27 status event code: A-6-3-E10-E12-rex-PB0901

B701 Decision to grant
PB0701 Decision of registration after re-examination before a trial

St.27 status event code: A-3-4-F10-F13-rex-PB0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20140610

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20140610

R17-X000 Change to representative recorded

St.27 status event code: A-5-5-R10-R17-oth-X000